WHO suspends clinical trials of hydroxychloroquine over safety concerns
DPI, Guyana, Monday, May 25, 2020 - The World Health Organization (WHO) today announced that it has suspended the clinical trials of hydroxychloroquine as a possible treatment for the novel coronavirus (COVID-19). Hydroxychloroquine is a drug used to prevent and treat malaria.
Additional Info
- Countries None
- Published in Health